Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027

Edwards Lifesciences EW has just entered Phase 18, the final stage of its 18-phase Adhishthana cycle on the weekly chart. While the stock's setup doesn't necessarily point to a bearish outlook, the structure suggests that sluggish, range-bound price action could dominate through early 2027. Tracking Edwards Lifesciences' Adhishthana Himalayan Formation According to the Adhishthana Principles, a stock typically breaks out of its Cakra formation in Phase 9, triggering a strong upward move. This marks the star ...